scispace - formally typeset
J

Judy Luden

Researcher at Cincinnati Children's Hospital Medical Center

Publications -  8
Citations -  508

Judy Luden is an academic researcher from Cincinnati Children's Hospital Medical Center. The author has contributed to research in topics: Randomized controlled trial & Transcranial Doppler. The author has an hindex of 4, co-authored 8 publications receiving 414 citations. Previous affiliations of Judy Luden include Georgia Regents University & Medical University of South Carolina.

Papers
More filters
Journal ArticleDOI

Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia - TCD with Transfusions Changing to Hydroxyurea (TWiTCH): A multicentre, open-label, phase 3, non-inferiority trial

TL;DR: High-risk children with sickle cell anaemia and abnormal TCD velocities who have received at least 1 year of transfusions, and have no MRA-defined severe vasculopathy, hydroxycarbamide treatment can substitute for chronic transfusions to maintain TCD velocity and help to prevent primary stroke.
Journal ArticleDOI

Comparison of transcranial color Doppler imaging (TCDI) and transcranial Doppler (TCD) in children with sickle-cell anemia

TL;DR: Moves to correlate transcranial arterial time-averaged mean velocities obtained from an Acuson Transcranial Doppler Imaging to those obtained using the TCD as the gold standard for treatment decisions based on STOP were compared.
Journal ArticleDOI

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Russell E. Ware, +44 more
- 03 Dec 2015 - 
TL;DR: Iron overload improved more in the hydroxyurea arm than in the transfusion arm, with a greater average change in serum ferritin, compared to -38 ng/mL, p.